Symlin is a prescription drug that helps to control blood sugar levels after meals in people with diabetes. This eMedTV article describes how to administer the drug, outlines potential side effects, and explains how the drug works.
Some of the most common side effects of Symlin can include nausea, vomiting, and fatigue. This eMedTV segment also takes an in-depth look at some of the more serious Symlin side effects, such as severe vomiting or symptoms of high or low blood sugar.
As this eMedTV segment explains, low and high blood sugar levels are possible effects of Symlin. Blood sugar levels that are too high or too low can lead to serious complications, so this page also highlights symptoms of high and low blood sugar.
This eMedTV resource explains how Symlin treats type 1 or type 2 diabetes by slowing down the increase in blood sugar after meals and decreasing the production of sugar in the liver. This page also discusses off-label Symlin uses.
This eMedTV article explains factors that affect the Symlin dosage, such as whether you have type 1 or type 2 diabetes and if you are taking other medicines. This page also lists tips on giving the injections and storing the drug.
This eMedTV resource explores potential Symlin drug interactions with other medications, such as pain medications, miglitol, and anticholinergics. This page also explains how these interactions can potentially increase your risk of side effects.
This eMedTV page discusses several Symlin warnings and precautions, such as the potential for allergic reactions, the risk of low blood sugar, and risks associated with taking the drug when pregnant. This page also lists those who should not take it.
This eMedTV article explores the results of animal studies on Symlin and pregnancy, explaining why the FDA has classified it as a pregnancy Category C medicine and outlining some of the complications the drug may cause.
Although rare, a Symlin overdose is possible. This portion of the eMedTV Web site describes possible effects of an overdose, such as severe vomiting, dizziness, or nausea. This page also outlines options that may be used to treat an overdose.
This page of the eMedTV library discusses why there is currently no approved generic Symlin available. This page also explains why the earliest date a generic version could become available is 2011 and warns against places claiming to sell it.
